Hashempur Mohammad Hashem, Ghorat Fereshteh, Karami Forough, Jahanbin Alireza, Nouraei Hasti, Abbasi Milad, Jafari Mahboobeh, Zare Alireza, Barzegar Sajjad, Zareshahrabadi Zahra
Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Int J Biomater. 2025 Jul 27;2025:4251091. doi: 10.1155/ijbm/4251091. eCollection 2025.
Plant-derived compounds have attracted considerable attention in the field of antimicrobial therapy. This interest is primarily due to their natural origin and historical evidence of their use in traditional medicine systems. These derivatives are a rich reservoir of chemical diversity that has a promising potential for the development and production of new antimicrobial agents with the least amount of side effects and risks of drug resistance. However, the delivery of plant-derived antimicrobial agents, especially through the topical route, poses significant challenges. As the largest organ of the body, the skin acts as a first barrier against the entrance of microbial pathogens. A primary limitation to transdermal delivery of plant-derived antimicrobial agents is their complex molecular structures, which often prevent effective absorption through the skin. Therefore, developing and promoting an effective local drug delivery system to increase the potential of antimicrobial therapy is very important and effective in public health. This review discusses delivery strategies for plant-derived antimicrobial agents aimed at the bioavailability and stability of these compounds as well as their mode of action, ensuring targeted delivery to the site of infection with long-lasting effects and minimizing side effects. Besides, various topical drug delivery platforms are analyzed, including nanoparticles, liposomes, and innovative application methods such as microneedles.
植物衍生化合物在抗菌治疗领域引起了广泛关注。这种关注主要源于其天然来源以及在传统医学体系中使用的历史证据。这些衍生物是化学多样性的丰富宝库,具有开发和生产副作用最小且耐药风险最低的新型抗菌剂的巨大潜力。然而,植物衍生抗菌剂的递送,尤其是通过局部途径递送,面临着重大挑战。作为人体最大的器官,皮肤是抵御微生物病原体进入的第一道屏障。植物衍生抗菌剂经皮递送的一个主要限制是其复杂的分子结构,这常常阻碍其通过皮肤有效吸收。因此,开发和推广有效的局部给药系统以提高抗菌治疗的潜力在公共卫生方面非常重要且有效。本综述讨论了针对植物衍生抗菌剂的递送策略,旨在提高这些化合物的生物利用度和稳定性以及它们的作用方式,确保靶向递送至感染部位并具有长效作用,同时将副作用降至最低。此外,还分析了各种局部给药平台,包括纳米颗粒、脂质体以及微针等创新应用方法。
Int J Biomater. 2025-7-27
Arch Ital Urol Androl. 2025-6-30
Psychopharmacol Bull. 2024-7-8
2025-1
Cochrane Database Syst Rev. 2017-6-14
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2022-9-20
Cochrane Database Syst Rev. 2017-6-22
Antioxidants (Basel). 2025-2-10
Biomed Res Int. 2022-9-12
Front Plant Sci. 2024-2-21
J Cosmet Dermatol. 2024-5